Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary Toggle99.5% of Tekmira Shareholders Vote in Favor of Merger Mar 03, 2015 99.5% of Tekmira Shareholders Vote in Favor of Merger 16.5 KB ... Read more Summary ToggleTekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc. Feb 25, 2015 Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc. 18.2 KB Board Nominees Complete for Combined Company ... Read more Summary ToggleTekmira to Present at RBC Capital Markets' Healthcare Conference Feb 12, 2015 Tekmira to Present at RBC Capital Markets' Healthcare Conference 12.1 KB ... Read more Summary ToggleTekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX Feb 04, 2015 Tekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX 27.2 KB Special Meeting of Shareholders to be Held March 3, 2015 ... Read more Summary ToggleTekmira Initiates Phase I Clinical Trial of TKM-HBV Jan 21, 2015 Tekmira Initiates Phase I Clinical Trial of TKM-HBV 24.4 KB TKM-HBV, a Leading RNAi Approach to Reduce Hepatitis B Surface Antigen, Has the Potential to Play a Central Role in the Cure of Chronic Hepatitis B Virus Infection ... Read more Summary ToggleTekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company Jan 11, 2015 Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company 38.6 KB ... Read more Summary ToggleTekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma Dec 31, 2014 Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma 83.6 KB ... Read more Summary ToggleTekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV Dec 22, 2014 Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV 25.6 KB TKM-HBV is Designed to Treat Patients Chronically Infected With Hepatitis B Virus ... Read more Summary ToggleTekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa Dec 22, 2014 Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa 25.6 KB ... Read more Summary ToggleTekmira Pharmaceuticals Announces Leadership Changes Dec 19, 2014 Tekmira Pharmaceuticals Announces Leadership Changes 17.6 KB ... Read more Pagination First page First Previous page Previous … Page 27 Current page 28 Page 29 Page 30 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary Toggle99.5% of Tekmira Shareholders Vote in Favor of Merger Mar 03, 2015 99.5% of Tekmira Shareholders Vote in Favor of Merger 16.5 KB ... Read more Summary ToggleTekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc. Feb 25, 2015 Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc. 18.2 KB Board Nominees Complete for Combined Company ... Read more Summary ToggleTekmira to Present at RBC Capital Markets' Healthcare Conference Feb 12, 2015 Tekmira to Present at RBC Capital Markets' Healthcare Conference 12.1 KB ... Read more Summary ToggleTekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX Feb 04, 2015 Tekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX 27.2 KB Special Meeting of Shareholders to be Held March 3, 2015 ... Read more Summary ToggleTekmira Initiates Phase I Clinical Trial of TKM-HBV Jan 21, 2015 Tekmira Initiates Phase I Clinical Trial of TKM-HBV 24.4 KB TKM-HBV, a Leading RNAi Approach to Reduce Hepatitis B Surface Antigen, Has the Potential to Play a Central Role in the Cure of Chronic Hepatitis B Virus Infection ... Read more Summary ToggleTekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company Jan 11, 2015 Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company 38.6 KB ... Read more Summary ToggleTekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma Dec 31, 2014 Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma 83.6 KB ... Read more Summary ToggleTekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV Dec 22, 2014 Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV 25.6 KB TKM-HBV is Designed to Treat Patients Chronically Infected With Hepatitis B Virus ... Read more Summary ToggleTekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa Dec 22, 2014 Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa 25.6 KB ... Read more Summary ToggleTekmira Pharmaceuticals Announces Leadership Changes Dec 19, 2014 Tekmira Pharmaceuticals Announces Leadership Changes 17.6 KB ... Read more Pagination First page First Previous page Previous … Page 27 Current page 28 Page 29 Page 30 … Next page Next Last page Last
Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc. 18.2 KB
Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company 38.6 KB
Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma 83.6 KB
Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa 25.6 KB
